echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > FDA approves Epson Bio to expand Dysport injection spree

    FDA approves Epson Bio to expand Dysport injection spree

    • Last Update: 2020-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, the, epson bio
    pharmaceutical(http://company(http://announced that the U.SFood andDrug(http://Administration (
    FDA(http://) has approved the expansion of the scope of Dysport (Lischuto, abobotulinumAtoxin, A botulinum atoxin) injectionsThe scope of application is included in the treatment of upper limb spasms in children 2 years and older (excluding spasms caused by cerebral palsy (cerebral palsy, CP)This approval is based on data from a key Phase III clinical studyThe study was a randomized, double-blind, low-dose, multicenter study that enrolled 210 children aged 2-17 with upper limb spasms   The results showed that Dysport significantly improved spasm symptoms and reached the main therapeutic end: the use of an improved Ashworth scale (MAS) to measure elbow or wrist flexor muscles, and at week 6, the baseline of two Dysport high dose groups (8U/kg, 16U/kg) movement disorders achieved a statistically significant improvement compared to the Dysport low dose group (2U/kg)   For most children, Dysport treatment reduces spasms in both the upper and lower limbs for 12 weeks In the upper limb study, most patients were treated at 16-28 weeks, but some patients had longer remission durations   The most common adverse reactions are upper respiratory tract infections and pharyngitis   About Dysport
    Dysport is an injectable Botulinum toxin type A, BoNT-A that is isolated and purified from the Clostridium difficile that produces BoNT-A, which is supplied as a freeze-dried powder In the United States, Dysport has been approved for the treatment of adult cervical vertebral tension disorder (CD) and the treatment of adult spasms   Dysport is the first and only FDA-approved Botox toxin for the treatment of upper limb and lower limb spasms in children two years of age or older   Dysport and all Botox products (http:// have a black-framed warning that the effects of Botox may spread from the injection site to other parts of the body, causing botulinum-like symptoms These symptoms include swallowing and breathing difficulties, which can be life-threatening   Dysport is prohibited for use in patients who are known to be allergic to any Botox toxin formulation or any ingredient, or to patients who are infected at the site of the proposed injection, or who are known to be allergic to bovine milk protein   Dysport's price unit is related to the preparation and analysis (http:// method used and is not interchangeable with other preparations for Botulinum toxin products
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.